Is There a Correlation Between APRI and FIB-4 with Fibrosure in Assessing Liver Fibrosis in Hepatitis C Patients?

被引:0
|
作者
Michael, E. Herman [1 ,2 ]
Emsieh, Saif [3 ]
Ermias, Jirru [4 ]
Paul, Kroner [4 ]
Olanma, Okoji [4 ]
Daniel, Castaneda [5 ]
Vijay, Dalapathi [4 ]
Praneet, Wander [4 ]
Kotler, Donald [4 ]
机构
[1] Mt Sinai St Lukes Hosp, New York, NY USA
[2] Mt Sinai West Hosp, New York, NY USA
[3] Jordan Univ Sci & Technol, Amman, Jordan
[4] Mt Sinai St Lukes & Mt Sinai Roosevelt, New York, NY USA
[5] Mt Sinai St Lukes & Mt Sinai West, New York, NY USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
886
引用
收藏
页码:S387 / S388
页数:2
相关论文
共 50 条
  • [1] Letter: APRI and FIB-4 do not correlate with Fibrosure in the evaluation of liver fibrosis in hepatitis C patients
    Herman, M.
    Okoji, O.
    Castaneda, D.
    Jirru, E.
    Kotler, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 190 - 191
  • [2] The value of APRI and FIB-4 scores in detection of liver fibrosis of patients with chronic hepatitis C
    Arikan, Hatice Burcu Acikalin
    Demirdal, Tuna
    Bilir, Neriman
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 663 - 668
  • [3] APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level
    Yen, Yi-Hao
    Kuo, Fang-Ying
    Kee, Kwong-Ming
    Chang, Kuo-Chin
    Tsai, Ming-Chao
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    Wang, Jing-Houng
    Hung, Chao-Hung
    Chen, Chien-Hung
    PLOS ONE, 2018, 13 (06):
  • [4] Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
    Jun Itakura
    Masayuki Kurosaki
    Hiroko Setoyama
    Tetsuro Simakami
    Noriko Oza
    Masaaki Korenaga
    Motohiko Tanaka
    Takuji Torimura
    Naoya Sakamoto
    Nobuyuki Enomoto
    Yoshiyuki Ueno
    Norifumi Kawada
    Shuichi Kaneko
    Shuhei Nishiguchi
    Kazuaki Chayama
    Junko Tanaka
    Namiki Izumi
    Tatsuya Kanto
    Journal of Gastroenterology, 2021, 56 : 470 - 478
  • [5] Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
    Itakura, Jun
    Kurosaki, Masayuki
    Setoyama, Hiroko
    Simakami, Tetsuro
    Oza, Noriko
    Korenaga, Masaaki
    Tanaka, Motohiko
    Torimura, Takuji
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Ueno, Yoshiyuki
    Kawada, Norifumi
    Kaneko, Shuichi
    Nishiguchi, Shuhei
    Chayama, Kazuaki
    Tanaka, Junko
    Izumi, Namiki
    Kanto, Tatsuya
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (05) : 470 - 478
  • [6] The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
    Huang, Dedong
    Lin, Taofa
    Wang, Shaoyang
    Cheng, Lieyun
    Xie, Liping
    Lu, Youguang
    Chen, Muxing
    Zhu, Lingling
    Shi, Jie
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [7] Comparison of APRI, FIB-4 and Fibro Test in Prediction of Fibrosis and Cirrhosis in Patients with Hepatitis C
    Zubair, Iram
    Wajid, Bilal
    PROCEEDINGS OF 2018 15TH INTERNATIONAL BHURBAN CONFERENCE ON APPLIED SCIENCES AND TECHNOLOGY (IBCAST), 2018, : 222 - 227
  • [8] The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
    Dedong Huang
    Taofa Lin
    Shaoyang Wang
    Lieyun Cheng
    Liping Xie
    Youguang Lu
    Muxing Chen
    Lingling Zhu
    Jie Shi
    BMC Infectious Diseases, 19
  • [9] The APRI and FIB-4 are equivalent in the estimation of fibrosis in chronic hepatitis
    Snyder, Ned
    Trang, Tony
    Xiao, Shu-Yuan
    Petersen, John R.
    GASTROENTEROLOGY, 2008, 134 (04) : A310 - A311
  • [10] Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus
    Imai, H.
    Kamei, H.
    Onishi, Y.
    Ishizu, Y.
    Ishigami, M.
    Goto, H.
    Ogura, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1431 - 1436